Condensed Consolidated Statements of Operations - Unaudited - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Operating expenses
Research and development		$ 25,617	$ 28,490
General and administrative		15,259	37,972
Total operating expenses		40,876	66,462
Operating loss		(40,876)	(66,462)
Interest income		5,297	0
Interest expense		(3)	(14)
Net loss before income taxes		(35,582)	(66,476)
Income tax expense		1,327	1,010
Net loss before noncontrolling interest		(36,909)	(67,486)
Net loss attributable to noncontrolling interest		(27,244)	0
Common Class A [Member]
Operating expenses
Net loss available to Class A ordinary shareholders		$ (9,665)	$ (67,486)
Weighted Average Number of Shares Outstanding, Basic	[1]	61,540,231
Weighted Average Number Of Shares Outstanding, Diluted	[1]	61,540,231
Net loss per share attributable to Class A ordinary shares, Basic	[1]	$ (0.16)
Net loss per share attributable to Class A ordinary shares, Diluted	[1]	$ (0.16)

[1] (1) The Company analyzed the calculation of net loss per share for periods prior to the Business Combination, as defined in Note 1, on July 11, 2022 and determined that it resulted in values that would not be meaningful to the users of the consolidated financial statements, as the capital structure completely changed as a result of the Business Combination. Therefore, net loss per share information has not been presented for periods prior to the Business Combination. For more information refer to Note 8.